Literature DB >> 2522832

T lymphocyte activation by staphylococcal enterotoxins: role of class II molecules and T cell surface structures.

B Fleischer1, H Schrezenmeier, P Conradt.   

Abstract

The enterotoxins produced by Staphylococcus aureus (SE) are the most potent mitogens known. Triggering of proliferation or cytotoxicity by SE requires the presence of MHC class II molecules on accessory or target cells. In this study we have investigated the role of HLA class II molecules in the activation of human T cells by SE and the nature of the target structure on the responding T lymphocyte for SE. This dependence on class II molecules is not due to an immunological "recognition" of SE since there is no restriction by polymorphic determinants of HLA molecules and since even xenogeneic class II molecules can reconstitute the human T cell response to SE. Furthermore, HLA class II-positive but not -negative cells absorb the mitogenic activity from SE solutions and significant binding of 125I-labeled SE can be demonstrated to class II-positive but not to class II-negative cells. Enterotoxin molecules react directly with T cells since they cause an increase in cytosolic Ca2+ concentration similar to anti-CD3 mAb. This increase is abrogated by prior modulation of the TCR/CD3 complex. Antibodies to CD2, CD3 and the TCR that block antigen-specific activation also block T cell activation by SE. Moreover, preincubation of purified resting accessory cell-free T cells with SE leads to modulation of the TCR/CD3 complex. Taken together these data indicate that SE interact selectively with HLA class II molecules on accessory or target cells and with a TCR-associated structure on the T cell.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522832     DOI: 10.1016/0008-8749(89)90177-9

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  24 in total

Review 1.  T lymphocyte-stimulating microbial toxins as "superantigens".

Authors:  B Fleischer
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

2.  B-cell maturation in chronic lymphocytic leukaemia. IV. T-cell-dependent activation of leukaemic B cells by staphylococcal enterotoxin 'superantigens'.

Authors:  X Duan; C Nerl; O Janssen; D Kabelitz
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

3.  Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.

Authors:  P A Lando; M Dohlsten; G Hedlund; T Brodin; D Sansom; T Kalland
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

Review 4.  Microbial "superantigens".

Authors:  M L Misfeldt
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

5.  Interaction of staphylococcal toxic shock syndrome toxin-1 and enterotoxin A on T cell proliferation and TNFα secretion in human blood mononuclear cells.

Authors:  M L De Boer; W W Kum; A W Chow
Journal:  Can J Infect Dis       Date:  1999-11

6.  Localization of binding sites of staphylococcal enterotoxin B (SEB), a superantigen, for HLA-DR by inhibition with synthetic peptides of SEB.

Authors:  J L Komisar; S Small-Harris; J Tseng
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

7.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).

Authors:  A Norrby-Teglund; D Newton; M Kotb; S E Holm; M Norgren
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo.

Authors:  Teresa Krakauer; Marilyn Buckley; Haleem J Issaq; Stephen D Fox
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

9.  Proinflammatory mediators of toxic shock and their correlation to lethality.

Authors:  Teresa Krakauer; Marilyn J Buckley; Diana Fisher
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

10.  Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release.

Authors:  B G Stiles; S Bavari; T Krakauer; R G Ulrich
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.